🇺🇸 🇪🇺 Kentino Internationl. We provide Covid-19 medical accessories - Kentino CZ 🇨🇿  Kentino SK🇸🇰

Categories

menu_banner1

-20%
off

CDC advisors recommend J&J COVID-19 vaccine

CDC advisors recommend J&J COVID-19 vaccine

An outside vaccine advisory panel for the Centers for Disease Control and Prevention (CDC) today voted to recommend the single-dose Johnson & Johnson COVID-19 vaccine after discussing study findings and policy and clinical considerations. Their interim recommendation, moving a third vaccine option just a step away from distribution, comes on the heels of the Food

FDA authorizes J&J 1-dose COVID vaccine

FDA authorizes J&J 1-dose COVID vaccine

The Food and Drug Administration (FDA) today issued an emergency use authorization (EUA) for the Johnson & Johnson COVID-19 vaccine, giving the United States a third vaccine to fight the pandemic—one that offers an easier, one-dose option. The formal announcement follows yesterday’s unanimous recommendation from the FDA’s outside advisory panel, the Vaccines and Related Biological

COVID-19 Scan for Feb 26, 2021

COVID-19 Scan for Feb 26, 2021

SARS-CoV-2 reinfects 5 in nursing home, causing worse disease, 1 death Five residents of a skilled nursing facility in Kentucky were likely reinfected with COVID-19, and the disease was worse the second time, with one patient dying, according to today’s Morbidity and Mortality Weekly Report (MMWR). Between the two outbreaks, which were reported in July

Stewardship / Resistance Scan for Feb 25, 2021

Stewardship / Resistance Scan for Feb 25, 2021

Danish study finds link between community C diff, proton pump inhibitors A nationwide study in Denmark found an association between the use of proton pump inhibitors (PPIs) and increased risk of community-associated Clostridioides difficile infections (CA-CDI), Danish researcher reported today in Clinical Infectious Diseases. For the study, researchers from Denmark’s Statens Serum Institute used the

COVID-19 Scan for Feb 24, 2021

COVID-19 Scan for Feb 24, 2021

COVID-19 antibodies may offer at least partial protection Americans with COVID-19 antibodies displayed 10-fold increased protection against infection 90 days after testing compared with those who had no antibodies, according to a study published today in JAMA Internal Medicine. The study tracked more than 50% of the commercial antibody and diagnostic tests administered in the

Stewardship / Resistance Scan for Feb 23, 2021

Stewardship / Resistance Scan for Feb 23, 2021

CARB-X to fund development of drug to rejuvenate ineffective antibiotics CARB-X announced today that it is awarding up to $2.2 million to the University of Queensland’s Institute for Molecular Bioscience (IMB) to continue developing new compounds designed to boost antibiotics that have become ineffective against drug-resistant bacterial infections. The award will help fund IMB’s octapeptins